| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $35.2M | +14.7% |
| SG&A Expense | $12.1M | +6.3% |
| Operating Income | -$47.3M | -12.4% |
| Interest Expense | $420K | +21.7% |
| Income Tax | $0 | — |
| Net Income | -$46.2M | -9.2% |
| EPS (Basic) | -$1.96 | -8.3% |
| EPS (Diluted) | -$1.96 | -8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.5M | -42.7% |
| Short-term Investments | $54.6M | +18.1% |
| Current Assets | $83.6M | -9.0% |
| Total Assets | $85.6M | -32.3% |
| Current Liabilities | $12.4M | +40.3% |
| Long-term Debt | $5.6M | +15.7% |
| Total Liabilities | $17.2M | +13.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.7M | -16.2% |
| Capital Expenditures | $8K | -91.4% |
| Investing Cash Flow | $23.7M | +129.9% |
| Financing Cash Flow | -$241K | -137.5% |
| Free Cash Flow | -$41.7M | -15.9% |
| Stockholders' Equity |
| $68.5M |
| -38.5% |